Envoy Medical Inc. (COCH)
NASDAQ: COCH
· Real-Time Price · USD
1.44
-0.02 (-1.37%)
At close: Aug 15, 2025, 11:26 AM
Envoy Medical Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -5.69M | -5M | -4.62M | -5.96M | -3.95M | -6.27M | -4.88M | 1.47M | -1.14M | 717.7K | -11.48M | -1.34M | 3.09M | 12.46M | -4.72M | 5.57M | 371.14K | -1.47M |
Depreciation & Amortization | 85K | 61K | 48K | 49K | 42K | 34K | 48K | 29K | 29K | 27K | 26K | 22K | 14K | 13K | 499.7K | n/a | n/a | n/a |
Stock-Based Compensation | 146K | 160K | 153K | 144K | 142K | 123K | 1.57M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | 81K | 85K | -478K | 814K | 8K | -433K | -4.82M | 3.73M | -733.74K | 920K | -181K | -23.69M | 514.23K | 527.53K | -68.99K | 2.37M | -1.49M | -1.14M |
Other Non-Cash Items | 922K | 130K | 401K | 1.8M | -1.55M | 1.46M | -1.64M | -5.12M | 1.19M | -3.82M | 8.58M | -521K | -4.11M | -13.76M | 3.9M | -8.59M | 228.5K | 1.37M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 77K | 922K | -372K | 1.16M | 403K | -1.19M | -6.81M | 4.71M | -733.74K | 920K | 490K | -640K | 622.54K | 527.53K | -68.99K | 2.32M | -1M | -1.15M |
Operating Cash Flow | -4.46M | -3.73M | -4.39M | -2.81M | -4.91M | -5.85M | -11.71M | 1.1M | -678.95K | -2.18M | -2.38M | -2.48M | -400.16K | -772.74K | -885.17K | -701.35K | -405.32K | -1.25M |
Capital Expenditures | -1K | -6K | 534K | -615K | -790K | -109K | -21K | -62K | -11K | -59K | -41K | -76K | -74K | -27K | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -425M | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -389.3M | 252K | 389.05M | 648.38K | 467.13K | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 389.3M | n/a | n/a | -648.38K | -467.13K | n/a | n/a | n/a | n/a | 420M | -420M |
Investing Cash Flow | -1K | -6K | 534K | -615K | -790K | -109K | -21K | -62K | 252K | 389.05M | -41K | -76K | -74K | -27K | n/a | n/a | -5M | -420M |
Debt Repayment | 4.76M | 4.77M | 5M | 7.5M | 2.5M | 5M | -563K | 3M | 3M | 4M | 2M | 3M | 1M | 2M | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 77K | n/a | n/a | n/a | n/a | n/a | n/a | 387.61M | -2 | -387.61M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | -607K | -1.21M | -614K | -1.83M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 2.21M | n/a | n/a | n/a | 563K | -387.61M | n/a | n/a | n/a | 92K | -250K | n/a | 3K | -6K | n/a | 423.38M |
Financial Cash Flow | 4.44M | 3.55M | 4.91M | 6.1M | 2.5M | 6.68M | -891K | 15.74M | 3M | 4M | 2M | 3.09M | 750K | 750K | 3K | -6K | 4.99M | 423.38M |
Net Cash Flow | -25K | -171K | 1.06M | 2.68M | -3.2M | 727K | -12.62M | 16.77M | 28.75K | -3.75K | -426K | 537K | 349.84K | -22.74K | -882.17K | -707.35K | -415.08K | 2.13M |
Free Cash Flow | -4.46M | -3.73M | -3.85M | -3.42M | -5.7M | -5.96M | -11.73M | 1.04M | -689.95K | -2.24M | -2.42M | -2.55M | -474.16K | -799.74K | -885.17K | -701.35K | -405.32K | -1.25M |